Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase A09.001: spumapepsin

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates

(Topics flags: S Structure, P Specificity, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2017
  1. Taylor,W.R., Stoye,J.P. and Taylor,I.A.
    A comparative analysis of the foamy and ortho virus capsid structures reveals an ancient domain duplication
    BMC Struct Biol17, 3-3. PubMed  Europe PubMed DOI
    2. 2014
  2. Schneider,A., Peter,D., Schmitt,J., Leo,B., Richter,F., Rosch,P., Wohrl,B.M. and Hartl,M.J.
    Structural requirements for enzymatic activities of foamy virus protease-reverse transcriptase
    Proteins82, 375-385. PubMed  Europe PubMed DOI
  3. Spannaus,R. and Bodem,J.
    Determination of the protease cleavage site repertoire - the RNase H but not the RT domain is essential for foamy viral protease activity
    Virology454-455, 145-156. PubMed  Europe PubMed DOI
    4. 2013
  4. Hutter,S., Mullers,E., Stanke,N., Reh,J. and Lindemann,D.
    Prototype Foamy Virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry
    J Virol87, 3163-3176. PubMed  Europe PubMed DOI
  5. Spannaus,R., Schneider,A., Hartl,M.J., Wohrl,B.M. and Bodem,J.
    Foamy virus Gag p71-p68 cleavage is required for template switch of the reverse transcriptase
    J Virol87, 7774-7776. PubMed  Europe PubMed DOI
    6. 2012
  6. Konvalinka,J. and Krausslich,H.G.
    Spumapepsins
    [ISSN:978-0-12-407744-7]3, 245-248. DOI
  7. Spannaus,R., Hartl,M.J., Wohrl,B.M., Rethwilm,A. and Bodem,J.
    The prototype foamy virus protease is active independently of the integrase domain
    Retrovirology9, 41-41. PubMed  Europe PubMed DOI
    8. 2011
  8. Hartl,M.J., Bodem,J., Jochheim,F., Rethwilm,A., Rosch,P. and Wohrl,B.M.
    Regulation of foamy virus protease activity by viral RNA: a novel and unique mechanism among retroviruses
    J Virol85, 4462-4469. PubMed  Europe PubMed DOI
  9. Lee,E.G., Roy,J., Jackson,D., Clark,P., Boyer,P.L., Hughes,S.H. and Linial,M.L.
    Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation
    J Virol85, 1655-1661. PubMed  Europe PubMed DOI
    10. 2010
  10. Hartl,M.J., Mayr,F., Rethwilm,A. and Wohrl,B.M.
    Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases
    Retrovirology7, 5-5. PubMed  Europe PubMed DOI
  11. Hartl,M.J., Schweimer,K., Reger,M.H., Schwarzinger,S., Bodem,J., Rosch,P. and Wohrl,B.M.
    Formation of transient dimers by a retroviral protease
    Biochem J427, 197-203. PubMed  Europe PubMed DOI
    12. 2008
  12. Eizert,H., Bander,P., Bagossi,P., Sperka,T., Miklossy,G., Boross,P., Weber,I.T. and Tozser,J.
    Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site
    J Virol82, 10111-10117. PubMed  Europe PubMed DOI  P
  13. Hartl,M.J., Wohrl,B.M., Rosch,P. and Schweimer,K.
    The solution structure of the simian foamy virus protease reveals a monomeric protein
    J Mol Biol381, 141-149. PubMed  Europe PubMed DOI  S
    14. 2007
  14. Roy,J. and Linial,M.L.
    Role of the foamy virus Pol cleavage site in viral replication
    J Virol81, 4956-4962. PubMed  Europe PubMed DOI  P
    15. 2006
  15. Sperka,T., Boross,P., Eizert,H., Tozser,J. and Bagossi,P.
    Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease
    Protein Eng Des Sel19, 369-375. PubMed  Europe PubMed DOI
    16. 2005
  16. Bagossi,P., Sperka,T., Feher,A., Kadas,J., Zahuczky,G., Miklossy,G., Boross,P. and Tozser,J.
    Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites
    J Virol79, 4213-4218. PubMed  Europe PubMed DOI  P
  17. Pfrepper,K.I. and Flugel,R.M.
    Molecular characterization of proteolytic processing of the Gag proteins of human spumaretrovirus
    Methods Mol Biol304, 435-444. PubMed  Europe PubMed DOI  P
    18. 2004
  18. Konvalinka,J. and Krausslich,H.G.
    Spumapepsins
    [ISSN:0-12-079610-4]2, 188-190.  V
    19. 2001
  19. Pfrepper,K.I., Reed,J., Rackwitz,H.R., Schnolzer,M. and Flugel,R.M.
    Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase
    Virus Genes22, 61-72. PubMed  Europe PubMed DOI
    20. 1999
  20. [YEAR:3-12-1999]Fenyofalvi,G., Bagossi,P., Copeland,T.D., Oroszlan,S., Boross,P. and Tozser,J.
    Expression and characterization of human foamy virus proteinase
    FEBS Lett462, 397-401. PubMed  Europe PubMed DOI  E
  21. Pfrepper,K.I., Lochelt,M., Rackwitz,H.R., Schnolzer,M., Heid,H. and Flugel,R.M.
    Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus
    J Virol73, 7907-7911. PubMed  Europe PubMed
    22. 1998
  22. Holzschu,D.L., Delaney,M.A., Renshaw,R.W. and Casey,J.W.
    The nucleotide sequence and spliced pol mRNA levels of the nonprimate spumavirus bovine foamy virus
    J Virol72, 2177-2182. PubMed  Europe PubMed
  23. Pfrepper,K.I., Rackwitz,H.R., Schnolzer,M., Heid,H., Lochelt,M. and Flugel,R.M.
    Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease
    J Virol72, 7648-7652. PubMed  Europe PubMed
  24. [YEAR:20-7-1998]Zemba,M., Wilk,T., Rutten,T., Wagner,A., Flugel,R.M. and Lochelt,M.
    The carboxy-terminal p3Gag domain of the human foamy virus gag precursor is required for efficient virus infectivity
    Virology247, 7-13. PubMed  Europe PubMed DOI
    25. 1997
  25. Enssle,J., Fischer,N., Moebes,A., Mauer,B., Smola,U. and Rethwilm,A.
    Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle
    J Virol71, 7312-7317. PubMed  Europe PubMed
  26. [YEAR:10-4-1997]Fischer,N., Enssle,J., Muller,J., Rethwilm,A. and Niewiesk,S.
    Characterization of human foamy virus proteins expressed by recombinant vaccinia viruses
    AIDS Res Hum Retroviruses13, 517-521. PubMed  Europe PubMed
  27. Giron,M.L., Colas,S., Wybier,J., Rozain,F. and Emanoil-Ravier,R.
    Expression and maturation of human foamy virus Gag precursor polypeptides
    J Virol71, 1635-1639. PubMed  Europe PubMed
  28. Pfrepper,K.I., Lochelt,M., Schnolzer,M. and Flugel,R.M.
    Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease
    Biochem Biophys Res Commun237, 548-553. PubMed  Europe PubMed DOI
    29. 1995
  29. Konvalinka,J., Lochelt,M., Zentgraf,H., Flugel,R.M. and Krausslich,H.G.
    Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein
    J Virol69, 7264-7268. PubMed  Europe PubMed
  30. Luukkonen,B.G., Tan,W., Fenyo,E.M. and Schwartz,S.
    Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system
    J Gen Virol76, 2169-2180. PubMed  Europe PubMed
    31. 1992
  31. Renne,R., Friedl,E., Schweizer,M., Fleps,U., Turek,R. and Neumann-Haefelin,D.
    Genomic organization and expression of simian foamy virus type 3 (SFV-3)
    Virology186, 597-608. PubMed  Europe PubMed DOI

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use